Rubius Therapeutics, Inc.(RUBY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RUBY Rubius Therapeutics, Inc.

Market Closed 12-05 16:00:00 EST Delay

{"stockData":{"symbol":"RUBY","market":"US","secType":"STK","nameCN":"Rubius Therapeutics, Inc.","latestPrice":0.057,"timestamp":1764968400000,"preClose":0.057,"halted":0,"volume":0,"delay":15,"floatShares":85465626,"shares":90483000,"eps":-1.989536,"marketStatus":"Market Closed","change":0,"latestTime":"12-05 16:00:00 EST Delay","open":0.057,"high":0.057,"low":0.057,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.989536,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"exchange":"EXPERT","adjPreClose":0.057,"volumeRatio":1.0932019855571937},"requestUrl":"/m/hq/s/RUBY","defaultTab":"news","newsList":[{"id":"2587375660","title":"Will Positive RUBY-3 Trial Results and Imminent FDA Filing Shift Vertex Pharmaceuticals' (VRTX) Kidney Disease Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2587375660","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587375660?lang=en_us&edition=fundamental","pubTime":"2025-11-29 08:22","pubTimestamp":1764375759,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals recently announced updated data from its RUBY-3 trial, showing that povetacicept led to substantial reductions in proteinuria and stabilization of kidney function in patients with IgA nephropathy and primary membranous nephropathy.\nThis candidate is currently the only BAFF+APRIL inhibitor in pivotal kidney disease trials, and Vertex is preparing for a rolling Biologics License Application submission for potential accelerated US FDA approval later this year.\nWe'll...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/will-positive-ruby-3-trial-results-and-imminent-fda-filing-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/will-positive-ruby-3-trial-results-and-imminent-fda-filing-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B19Z3B42.SGD","RUBY","BK4533","LU0109394709.USD","LU0417517546.SGD","LU2417539215.USD","IE0002141913.USD","BK4567","LU1674673691.USD","VRTX","IE00B894F039.SGD","LU0823416689.USD","LU0432979614.USD","LU0889565916.HKD","SG9999013999.USD","IE0009355771.USD","BK4139","BK4532","LU0289739699.SGD","LU2236285917.USD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU0566484027.USD","LU0256863811.USD","LU1093756325.SGD","LU1674673428.USD","LU1069344957.HKD","LU1778281490.HKD","LU2462157665.USD","SG9999001176.USD","SGXZ57979304.SGD","BK4535","LU0757428866.USD","IE00B19Z9P08.USD","LU1093756168.USD","LU0234570918.USD","LU1585245621.USD","LU2456880835.USD","LU0079474960.USD","LU2362540622.SGD","LU2237438978.USD","LU2362541513.USD","IE00B19Z9Z06.USD","LU1035775433.USD","IE00B2B36J28.USD","BK4585","VERX","BK4588","IE00B19Z3581.USD","IE00BZ9MQY76.HKD"],"gpt_icon":0},{"id":"2582818836","title":"Vertex Pharmaceuticals announces updated data from RUBY-3 study of povetacicept","url":"https://stock-news.laohu8.com/highlight/detail?id=2582818836","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582818836?lang=en_us&edition=fundamental","pubTime":"2025-11-10 01:15","pubTimestamp":1762708525,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) announced updated data for povetacicept in IgA nephropathy and primary membranous nephropathy from the ongoing RUBY-3...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-announces-updated-data-from-ruby-3-study-of-povetacicept-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-announces-updated-data-from-ruby-3-study-of-povetacicept-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2362541273.HKD","IE00BJT1NW94.SGD","RUBY","LU2456880835.USD","SG9999001176.SGD","VERX","LU0256863811.USD","SG9999013999.USD","BK4139","LU0061475181.USD","LU2417539215.USD","IE0002270589.USD","LU2236285917.USD","LU0109394709.USD","LU1585245621.USD","IE00B19Z9P08.USD","SGXZ57979304.SGD","LU2362540622.SGD","LU2362541513.USD","LU2462157665.USD","LU1815336091.USD","BK4532","LU0234570918.USD","LU1778281490.HKD","LU1093756325.SGD","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU0058720904.USD","IE00BZ9MQY76.HKD","SG9999001176.USD","LU2237438978.USD","LU1674673428.USD","IE00B4R5TH58.HKD","VRTX","LU0320765992.SGD","BK4535","BK4023","LU0417517546.SGD","LU1035775433.USD","BK4567","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","LU1069344957.HKD","LU0566484027.USD","IE0009355771.USD","LU0823416689.USD","IE0002141913.USD","LU0757428866.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rubiustx.com","description":"Rubius Therapeutics, Inc., a biopharmaceutical company, focuses on the development of red cell therapeutics for the treatment of cancer and autoimmune diseases. The company was formerly known as VL26, Inc and as changed its name to Rubius Therapeutics, Inc. in 2015. Rubius Therapeutics, Inc. was incorporated in 2013 and is based in Foxborough, Massachusetts.","exchange":"EXPERT","name":"Rubius Therapeutics, Inc.","nameEN":"Rubius Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rubius Therapeutics, Inc.(RUBY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Rubius Therapeutics, Inc.(RUBY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Rubius Therapeutics, Inc.,RUBY,Rubius Therapeutics, Inc.股票,Rubius Therapeutics, Inc.股票老虎,Rubius Therapeutics, Inc.股票老虎国际,Rubius Therapeutics, Inc.行情,Rubius Therapeutics, Inc.股票行情,Rubius Therapeutics, Inc.股价,Rubius Therapeutics, Inc.股市,Rubius Therapeutics, Inc.股票价格,Rubius Therapeutics, Inc.股票交易,Rubius Therapeutics, Inc.股票购买,Rubius Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rubius Therapeutics, Inc.(RUBY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Rubius Therapeutics, Inc.(RUBY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction